IRIS
DAMIANO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.395
NA - Nord America 2.078
EU - Europa 1.697
SA - Sud America 259
AF - Africa 67
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.001
SG - Singapore 1.037
RU - Federazione Russa 770
VN - Vietnam 481
CN - Cina 446
IT - Italia 271
HK - Hong Kong 215
BR - Brasile 204
UA - Ucraina 127
DE - Germania 117
FR - Francia 84
NL - Olanda 73
FI - Finlandia 72
CA - Canada 49
IE - Irlanda 45
GB - Regno Unito 44
IN - India 33
JP - Giappone 33
SE - Svezia 33
AR - Argentina 22
BD - Bangladesh 22
KR - Corea 20
CI - Costa d'Avorio 18
MX - Messico 18
ZA - Sudafrica 17
PH - Filippine 16
PL - Polonia 14
IQ - Iraq 13
BE - Belgio 11
TH - Thailandia 11
ES - Italia 10
PK - Pakistan 9
EC - Ecuador 8
TW - Taiwan 8
CO - Colombia 7
MA - Marocco 7
PY - Paraguay 7
VE - Venezuela 7
AT - Austria 6
ID - Indonesia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
TR - Turchia 5
UZ - Uzbekistan 5
JO - Giordania 4
LB - Libano 4
AU - Australia 3
BB - Barbados 3
EG - Egitto 3
JM - Giamaica 3
NP - Nepal 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
LT - Lituania 2
MY - Malesia 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
HT - Haiti 1
KG - Kirghizistan 1
KW - Kuwait 1
MN - Mongolia 1
MW - Malawi 1
NC - Nuova Caledonia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RE - Reunion 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
TL - Timor Orientale 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.500
Salva come PNG Salva come JPEG
Città #
Singapore 519
San Jose 325
Hong Kong 203
Moscow 198
Beijing 169
Chandler 166
Ashburn 164
Ho Chi Minh City 144
Jacksonville 126
Hanoi 99
Santa Clara 80
Naples 71
Amsterdam 68
Los Angeles 65
Hefei 61
Millbury 61
Lauterbourg 48
Munich 48
The Dalles 46
Woodbridge 44
Princeton 42
Dallas 41
New York 35
Buffalo 27
Ottawa 27
Tokyo 26
Da Nang 25
Nanjing 25
Wilmington 22
Haiphong 21
San Giovanni Rotondo 19
Boston 18
Napoli 17
Houston 15
Milan 15
Orem 15
Turku 14
São Paulo 13
London 11
Brooklyn 10
Helsinki 10
Montreal 10
Nanchang 10
Norwalk 10
Seoul 10
Stockholm 10
Warsaw 10
Chicago 9
Redondo Beach 9
Shenyang 9
Atlanta 8
Biên Hòa 8
Boardman 8
Brussels 8
Denver 8
Frankfurt am Main 8
Johannesburg 8
Kochi 8
Nuremberg 8
Can Tho 7
Phoenix 7
Seattle 7
Changsha 6
Council Bluffs 6
Des Moines 6
Mexico City 6
Salerno 6
Bangkok 5
Chennai 5
Hải Dương 5
Pescara 5
Quận Ba 5
Rio de Janeiro 5
Tashkent 5
Thái Nguyên 5
Tianjin 5
Toronto 5
Vienna 5
Amman 4
Baghdad 4
Bogotá 4
Casablanca 4
Falkenstein 4
Florence 4
Guarulhos 4
Hebei 4
Hicksville 4
Kronberg 4
Mumbai 4
Palma Campania 4
Querétaro 4
Rome 4
Andrano 3
Asunción 3
Bexley 3
Bridgetown 3
Buenos Aires 3
Campo Grande 3
Caserta 3
Charlotte 3
Totale 3.498
Salva come PNG Salva come JPEG
Nome #
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 171
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. 155
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 155
Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials 154
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 153
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 147
Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer 145
Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia 144
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 143
Paraneoplastic sensitive neuropathy associated with anti-hu antibodies in a neuroendocrine tumor of duodenum: a case report. 142
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. 140
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. 137
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. 131
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. 129
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 129
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs 129
Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics 128
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 126
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 126
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 125
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. 124
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients 124
Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments. 121
Imatinib mesylate in thymic epithelial malignancies. 120
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. 117
Combination of biological therapies in non-small cell lung cancer. 115
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. 115
The mechanisms of resistance to EGFR inhibitors. 115
A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action 115
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. 114
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 112
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. 111
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. 110
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 109
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 109
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 108
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 107
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma 106
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. 104
Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector. 103
Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents. 101
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 98
Case Report: Unresectable recurrent nasopharyngeal cancer treated with immuno oncology 95
Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers. 95
Novel TLR9 agonist induces EGFR inhibition and synergistic antitumor activity with EGFR inhibitors. 93
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. 92
Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits. 91
Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: An observational retrospective-prospective analysis from real life 91
Dissecting the link between PD-1/PD-L1-based immunotherapy and cancer pain: mechanisms, research implications, and artificial intelligence perspectives 90
Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production. 82
The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 81
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene. 1997 Feb 27;14(8):923-8. 79
Differential effects of type I and type II protein kinase A isoforms on chinese hamster ovary cell cycle and proliferation. 74
Clear Cell Neoplasm in Salivary Gland FNA? Maybe It’s From Kidney! 73
Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy 66
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. 60
Tumori rari 52
Long term deficiency of vitamin D in germ cell testicular cancer survivors 50
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin–bleomycin–vinblastine–dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study 39
Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience 2
Totale 6.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022310 2 0 0 4 4 8 7 11 46 23 89 116
2022/2023404 48 40 13 20 41 52 0 31 62 67 23 7
2023/2024280 8 40 30 45 26 20 3 29 5 14 45 15
2024/20251.674 70 93 4 8 64 64 185 104 70 179 675 158
2025/20263.264 365 231 360 313 588 133 360 144 443 225 72 30
Totale 6.572